Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04726852 · ClinicalTrials.gov registry record
Arterial Pressure vs. TE Echo dp/dt
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 43
- Enrollment target
NCT04726852: Completed study, sponsored by University of California, Davis.
NCT04726852 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04726852 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This study seeks to assess the strength of correlation between arterial pressure waveform derived contractility as quantified by the maximal rate of pressure change ans a function of time (dp/dtmax) and transesophageal echocardiographically (TEE) determined contractility, also quantified by dp/dtmax. In addition, correlations between dp/dtmax. In addition, TEE derived assessment of ejection fraction will provide guidance for relating this new parameter with other standard contractility assessments.
Primary Outcome
The correlation between dp/dtmax as calculated by the Hypotension Prediction Index (HPI) software and dp/dtmax as calculated by TEE mitral regurgitation jet analysis.
Interventions
- DEVICE Concurrent comparison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-02-02 |
| Est. Completion | 2024-10-01 |
What the finished NCT04726852 record still lists
NCT04726852 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Concurrent comparison is the first listed.
NCT04726852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04726852 about?
NCT04726852 is a clinical study titled "Arterial Pressure vs. TE Echo dp/dt". This study seeks to assess the strength of correlation between arterial pressure waveform derived contractility as quantified by the maximal rate of pressure change ans a function of time (dp/dtmax) and transesophageal echocardiographically (TEE) determined contractility, also quantified by dp/dtmax...
What is the current status of trial NCT04726852?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2021-02-02. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT04726852?
The interventions under investigation include: Concurrent comparison (DEVICE).
Who is sponsoring clinical trial NCT04726852?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI